11.07.10 Lysaker – Norwegian biopharmaceutical company PCI Biotech Holding ASA has strengthened the company’s equity by a11m (NOK90m) through a share issue of 2.25 million shares with preemptive subscription rights for existing...
more
11.07.10 London/Copenhagen – British drugmaker GlaxoSmithKline has changed the conditions of its EUR1.2bn licensing agreement with Danish antibody specialist Genmab. GSK announced it will take over responsibility for developing Genmab’s...
more
11.07.10 Stockholm – The Swedish Research Council is commissioning the Stockholm-based Karolinska Institute to host two new national infrastructures for research in biomedicine: the BioBanking and Molecular Resource Infrastructure of...
more
11.07.10 Personalised diagnostics open up possibilities for reducing adverse drug effects and choosing the most effective medicine for an individual patient based on a set of biomarkers. While many disease and stratification biomarkers...
more
10.07.10 Copenhagen/Washington – Citing the report “The Future of Industrial Biorefineries” during a keynote address at the BIO World Congress conference in Washington at the end of June, the CEO of Danish biotech Novozymes, Steen...
more
